NeuroOne Medical Technologies Corp. (NMTC)
4.54
+0.01
(+0.22%)
USD |
NASDAQ |
May 19, 10:09
NeuroOne Medical Technologies Research and Development Expense (Quarterly) : 1.468M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Artivion, Inc. | 8.841M |
| Edwards Lifesciences Corp. | 263.30M |
| Zimmer Biomet Holdings, Inc. | 103.40M |
| PetVivo Holdings, Inc. | 0.323M |
| INVO Fertility, Inc. | 0.00 |